跳至主要内容
临床试验/NCT00234390
NCT00234390已完成4 期

Prevention of Asthma in Infants/Young Children - PAC

AstraZeneca1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 1998年11月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
AstraZeneca
入组人数
400
试验地点
1
主要终点
symptom free days

研究概览

简要总结

The purpose of this study is to investigate the ability of budesonide, given during episodes of troublesome lung symptoms to reduce further symptoms in infants and young children at risk of developing asthma

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
— 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Children of asthmatic mothers form the COPSAC birth cohort study

排除标准

  • Children born more than 4 weeks preterm
  • children with other systemic illness that atopy/allergy
  • Children requiring mechanical ventilation at any time since birth.

结局指标

主要结局

symptom free days

days with no use of bronchodilator

days with no use of bronchodilator and no symptoms

number of treated episodes

number of treatment with add-on medication

次要结局

  • asthma status
  • time to start of algorithm treatment
  • the total steroid dose
  • First treatment episode:
  • number of symptom days
  • number of days with use of bronchodilator
  • number of patients who needed add-on medication
  • BMD
  • height
  • serious adverse events

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

PreAsthmaControl (PAC) | 临床试验